Females | Males | |||
---|---|---|---|---|
Mortality rate ratio (95% CI) | p-value | Mortality rate ratio (95% CI) | p-value | |
BSI, all | 1.014 (0 .965–1.067) | 0.58 | 0.974 (0.933–1.017) | 0.23 |
Place of acquisition | ||||
Community acquired | 0.917 (0.838–1.002) | 0.056 | 0.979 (0.8980–1.068) | 0.64 |
Health care-associated | 1.074 (0.999–1.154) | 0.052 | 0.982 (0.928–1.039) | 0.53 |
Hospital acquired | 0.998 (0.882–1.129) | 0.97 | 0.915 (0.825–1.015) | 0.095 |
Infection focus | ||||
Urinary tract | 0.989 (0.893–1.095) | 0.83 | 1.114 (1.001–1.239) | 0.047 |
Lungs | 1.018 (0.908–1.140) | 0.76 | 0.910 (0.838–0.988) | 0.024 |
Biliary tract | 0.982 (0.740–1.303) | 0.90 | 1.030 (0.867–1.226) | 0.73 |
Gastrointestinal tract | 0.978 (0.800–1.195) | 0.83 | 0.891 (0.724–1.097) | 0.28 |
Skin or soft tissue | 1.007 (0.855–1.186) | 0.93 | 0.994 (0.880–1.122) | 0.92 |
Other | 0.913 (0.782–1.065) | 0.25 | 1.024 (0.879–1.193) | 0.76 |
Unknown | 1.086 (0.981–1.202) | 0.11 | 0.922 (0.836–1.017) | 0.10 |
Microbe group | ||||
Gram-negative BSI | 1.023 (0.953–1.098) | 0.53 | 1.011 (0.941–1.085) | 0.77 |
Gram-positive BSI | 0.999 (0.921–1.084) | 0.99 | 0.937 (0.884–0.993) | 0.027 |
Polymicrobial or fungal BSI | 0.952 (0.829–1.093) | 0.49 | 1.072 (0.911–1.260) | 0.40 |
Microbes (the four most common) | ||||
Escherichia coli | 1.014 (0.911–1.129) | 0.79 | 0.957 (0.964–1.060) | 0.40 |
Streptococcus pneumoniae | 0.971 (0.812–1.161) | 0.75 | 0.850 (0.745–0.971) | 0.017 |
Staphylococcus aureus | 0.985 (0.880–1.103) | 0.80 | 0.972 (0.882–1.070) | 0.56 |
Klebsiella spp. | 1.169 (0.960–1.425) | 0.12 | 1.107 (0.916–1.338) | 0.29 |